Effect of UC Versus EA on Sex Hormones in Obese Infertile Patients With PCOs

Sponsor
Mohamed Abdel Hamid elgaedy (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04875312
Collaborator
(none)
40
2
3.1

Study Details

Study Description

Brief Summary

The aim of this study is to determine the difference between the effect of Ultrasound Cavitation and Elctroacupuncture on sex hormones in obese infertile patients with poly cystic ovarian syndrome …………………………………………………………………… BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that occurs in 6 - 10% of women at the reproductive age. It is associated with an-ovulation, infertility, hyperandrogenism, obesity and insulin resistance.

Endocrine characteristics of PCOS are elevated serum concentrations of androgens and Luteinizing hormone (LH) and decreased concentrations of sex hormone binding globulin (SHBG).

Ultrasound cavitation is the method in handling Subcutaneous Adipose Tissue (, especially in destroying subcutaneous fat and shaping a particular part of the body. As one of the non-surgical correction method, UC is preferred for lowering the risk of complications due to obesity.

UC reported a greater decrease of the WHR, suggesting a valuable modification of fat distribution pattern, especially at the abdominal level. It improves rates of ovulation, provides higher incidence of regular menstrual cycles and lower levels of total testosterone.

Acupuncture is a treatment method used in Traditional Chinese Medicine. Electroacupuncture promotes follicle development and corrects reproductive endocrine dysfunction in ovaries by regulating the functions of the hypothalamus, pituitary and ovaries

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasound cavitation in group A
  • Device: Electro acupuncture in group B
N/A

Detailed Description

This study will be designed as prospective, randomized, single blind, experimental, pre-post test , controlled- trial study.

Simple Size Calculation:
I- Subjects:

Forty obese infertile patients with poly cystic ovarian syndrome will participate in this study to determine the difference between the effect of Ultrasound Cavitation and Elctroacupuncture on sex hormones. They will be selected randomly from Out Patient Clinic of Aga Hospital Central, in Aga. All patients will be divided randomly into two equal groups (A&B).

Group A:

twenty obese infertile patients with PCO who will be treated by ultrasound cavitation, 2 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)

Group B:

twenty obese infertile patients with PCO who will be treated by electroacupuncture, 3 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day) II-

Instrumentations:
  1. Recording data sheet (Appendix II).

  2. Standard weight height scale: measure BMI

  3. Tape measurement: measure waist/hip ratio.

  4. Test tubes: used to collect the blood samples from obese infertile patients

  5. Kites: used for assessment of serum progesterone level, testosterone, LH and FSH.

  6. Abdominal ultrasongraphy: measure ovulation rate.

  7. cavitation in group A 8- electroacupuncture in group B

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect of Ultrasound Cavitation Versus Electro Acupuncture on Sex Hormones in Obese Infertile Patients With Polycystic Ovarian Syndrome
Anticipated Study Start Date :
Apr 30, 2021
Anticipated Primary Completion Date :
Jul 1, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group USC

Effect of ultrasound cavitation sessions on sex hormones in obese infertile patients with poly cystic ovarian syndrome

Device: Ultrasound cavitation in group A
Group A: twenty obese infertile patients with PCO who will be treated by ultrasound cavitation, 2 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)

Experimental: Group EA

Effect of electro acupuncture on sex hormones in obese infertile patients with poly cystic ovarian syndrome

Device: Electro acupuncture in group B
Group B: twenty obese infertile patients with PCO who will be treated by electroacupuncture, 3 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)

Outcome Measures

Primary Outcome Measures

  1. weight [up to 12 weeks]

    It will be use weight scale to measure weight to calculate the body mass index (BMI) for each woman.

  2. waist/hip ratio: [up to 12 weeks]

    It will be use tape measurement to calculate the waist/hip ratio.

  3. Testosterone hormones : [up to 12 weeks]

    They will be use kites for assessment of level of testosterone hormones

  4. FSH Hormone [up to 12 weeks]

    They will be use kites for assessment of level of FSH hormones

  5. Lh hormones [up to 12 weeks]

    They will be use kites for assessment of level of LH hormones

  6. Progesterone hormones [up to 12 weeks]

    They will be use kites for assessment of level of progesterone hormones

  7. Height [up to 12 weeks]

    It will be use tape measurement to measure height to calculate the body mass index (BMI) for each woman.

Secondary Outcome Measures

  1. Ovulation rate [up to 12 weeks]

    It will be use ultrasonography for measuring ovulation rate.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Their ages will be ranged between 20-35 year old.

  2. Their body mass index will be ranged from 30-40 kg/m2.

  3. All of them are married women.

Exclusion Criteria:
  • Women will be excluded if they have one of the following criteria:
  1. Diabetes mellitus.

  2. Thyroid dysfunction.

  3. Concomitant cardiovascular disorders.

  4. Respiratory, renal and liver dysfunction.

  5. Tubal adhesions as well as uterine abnormalities.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Mohamed Abdel Hamid elgaedy

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Mohamed Abdel Hamid elgaedy, Head OF physical therapy in AGA hospital, Cairo University
ClinicalTrials.gov Identifier:
NCT04875312
Other Study ID Numbers:
  • 012/003187
First Posted:
May 6, 2021
Last Update Posted:
May 7, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 7, 2021